Patient Preferences for Surgical Versus Medical Therapy for Ulcerative Colitis

T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study

(2012) Parakkal Deepak et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sixty-year Study of Incidence of Childhood Ulcerative Colitis Finds Eleven-fold Increase Beginning in 1990s

(2012) Vered Schildkraut et al.   INFLAMMATORY BOWEL DISEASES

Perceived and Actual Quality of Life With Ulcerative Colitis: A Comparison of Medically and Surgically Treated Patients

(2011) Akbar K Waljee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proximity to Disease and Perception of Utility: Physiciansʼ vs Patientsʼ Assessment of Treatment Options for Ulcerative Colitis

(2011) Lindsay Kennedy Brown et al.   DISEASES OF THE COLON & RECTUM

Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options

(2011) Corey A Siegel   GUT

Eliciting Benefit–Risk Preferences and Probability-Weighted Utility Using Choice-Format Conjoint Analysis

(2011) George Van Houtven et al.   MEDICAL DECISION MAKING

The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006

(2011) Lisa J. Herrinton et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

(2011) John F.P. Bridges et al.   VALUE IN HEALTH

Individual health discount rate in patients with ulcerative colitis

(2010) Akbar K. Waljee et al.   INFLAMMATORY BOWEL DISEASES

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy

(2009) F. Reed Johnson et al.   JOURNAL OF NEUROLOGY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

(2008) James D. Lewis et al.   INFLAMMATORY BOWEL DISEASES